Altre lingue Acrobiosystems Co.,Ltd.

Azioni

301080

CNE100004S13

Prezzo di chiusura Shenzhen S.E. Altri mercati azionari 00:00:00 21/06/2024			Variaz. 5gg	Var. 1 gen.
37,4 ^CNY	+2,02%		-0,37%	-36,55%

18/04	Acrobiosystems Co.,Ltd. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
10/04	ACROBiosystems lancia le soluzioni Organoidi 3D, spingendo le nuove frontiere della ricerca bioterapeutica.	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

SyntekaBio, Inc. signed Memorandum of Understanding to acquire bioSeedin from Acrobiosystems Co.,Ltd..	20/06
Acrobiosystems Co.,Ltd. Approves Cash Dividend for 2023	15/05
Acrobiosystems Co.,Ltd. Proposes Final Cash Dividend for 2023	24/04
Acrobiosystems Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	18/04
ACROBiosystems Launches 3D Organoid Solutions, Propelling New Frontiers in Biotherapeutic Research	10/04
Tranche Update on Acrobiosystems Co.,Ltd.'s Equity Buyback Plan announced on July 18, 2023.	18/01
Acrobiosystems Co.,Ltd.'s Equity Buyback announced on July 18, 2023, has closed with 273,800 shares, representing 0.23% for CNY 16 million.	17/01
Tranche Update on Acrobiosystems Co.,Ltd.'s Equity Buyback Plan announced on July 18, 2023.	03/01
Acrobiosystems Launches Gmp Grade Dll4 Protein to Accelerate Stem Cell Manufacturing	16/11
Acrobiosystems Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	29/10/23
Tranche Update on Acrobiosystems Co.,Ltd.'s Equity Buyback Plan announced on July 18, 2023.	10/10/23
Acrobiosystems Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	28/08/23
Acrobiosystems Co.,Ltd. Approves Board Elections	03/08/23
Acrobiosystems Co.,Ltd. announces an Equity Buyback for CNY 30 million worth of its shares.	17/07/23
Acrobiosystems Co.,Ltd. authorizes a Buyback Plan.	17/07/23
ACROBiosystems, Through ACRO Certify and Under its Aneuro Brand, Announces Launch of in Vivo Electrophysiology Solutions for Neuroscience Research with Diagnostic Biochips	09/06/23
Acrobiosystems Co.,Ltd. Approves the Cash Dividend for the Year 2022, Payment Date: 07 June 2023	31/05/23
Acrobiosystems Co.,Ltd. Approves the Cash Dividend for the Year 2022	17/05/23
Acrobiosystems Co.,Ltd. Proposes Final Cash Dividend for the Year 2022	26/04/23
Acrobiosystems Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	25/04/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Acrobiosystems Co.,Ltd.

Azioni

301080

CNE100004S13

Altre lingue

Filtri